Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus.

Cappuzzo F, Moro-Sibilot D, Gautschi O, Boleti E, Felip E, Groen HJ, Germonpré P, Meldgaard P, Arriola E, Steele N, Fox J, Schnell P, Engelsberg A, Wolf J.

Journal: Lung Cancer
Veröffentlichung: Feb. 2015